USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Vioxx Recall - Revenue Analysis and Impact on Cox-2 Inhibitor Markets
Vioxx Recall - Revenue Analysis and Impact on Cox-2 Inhibitor Markets
RELEASE DATE
23-Nov-2004
23-Nov-2004
REGION
North America
North America
Research Code: F135-01-00-00-00
SKU: HC01414-NA-MR_05861
$2,450.00
In stock
SKU
HC01414-NA-MR_05861
Description
The research service provides an analysis of Cox-2 inhibitors in three possible scenarios. A pessimistic, conservative, and optimistic scenario is manipulated by impacting factors. Included in each scenario are drug revenue forecasts, number of patients anticipated to shift from Vioxx, patient forecasts and analysis.
Table of Contents
Market Analysis Before Recall
- Overview and Research Methodology
- Indications
- Pricing Trends
- Patient Forecasts
- Revenue Forecasts
Market Analysis After Recall
- Patients Shifting
- Pessimistic Scenario
- Conservative Scenario
- Optimistic Scenario
- Recommendations and Conclusion
Decision Support Databases
- Arthritis Prevalence
- Population 55 and Above
- Cardiologists
- Stroke Incidence
- Orthopaedists
Popular Topics
plastic waste management market
residential energy storage market
The research service provides an analysis of Cox-2 inhibitors in three possible scenarios. A pessimistic, conservative, and optimistic scenario is manipulated by impacting factors. Included in each scenario are drug revenue forecasts, number of patients anticipated to shift from Vioxx, patient forecasts and analysis.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | F135-01-00-00-00 |
| Is Prebook | No |